Page 1 of Clinical Trials for Drug Basiliximab Simulect, 94 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Last Updated: August 17, 2010
Condition(s): Non-infectious Uveitis
2
Completed
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
Last Updated: August 9, 2011
Condition(s): Kidney Transplantation
3
Not yet recruiting
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Last Updated: December 2, 2011
Condition(s): Graft Versus Host Disease; Steroid Refractory GVHD; Acute GVH Disease
4
Not yet recruiting
Pharmacodynamics, Efficacy, Safety of Basiliximab 40 or 80 mg Combined With CsA or Everolimus, in Low Risk de Novo Renal Transplant Recipients
Last Updated: March 1, 2012
Condition(s): Renal Transplantation
5
Recruiting
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
Last Updated: May 8, 2012
Condition(s): Renal Transplantation
6
Completed
Basiliximab in Moderate to Severe Ulcerative Colitis
Last Updated: December 17, 2008
Condition(s): Ulcerative Colitis
7
Recruiting
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
Last Updated: May 24, 2011
Condition(s): Reduction in Sequelae Related to Calcineurin Inhibitors; Chimeric Antibody Sensitization; Allograft Rejection
8
Active, not recruiting
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Last Updated: May 15, 2012
Condition(s): Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Non-Hodgkin's Lymphoma; Hodgkin's Disease; Multiple Myeloma; Myelofibrosis; Anemia, Aplastic; Hemoglobinuria, Paroxysmal
9
Terminated
Basiliximab Maintenance in Ulcerative Colitis
Last Updated: February 2, 2010
Condition(s): Ulcerative Colitis
10
Completed
Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation
Last Updated: February 26, 2009
Condition(s): Kidney Transplantation
11
Completed
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Last Updated: August 10, 2011
Condition(s): Kidney Transplantation
12
Completed
Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids
Last Updated: August 17, 2011
Condition(s): Liver Transplantation; Infection
13
Not yet recruiting
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
Last Updated: November 18, 2011
Condition(s): Recurrent Adult Hodgkin Lymphoma
14
Recruiting
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance
Last Updated: June 9, 2011
Condition(s): Kidney Transplant
15
Active, not recruiting
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
Last Updated: September 8, 2011
Condition(s): Brain and Central Nervous System Tumors
16
Completed
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients
Last Updated: December 12, 2006
Condition(s): Corneal Transplantation
17
Recruiting
Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
Last Updated: July 6, 2010
Condition(s): Graft vs Host Disease; Hematopoietic Stem Cell Transplantation
18
Completed
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Last Updated: July 31, 2009
Condition(s): Cadaveric Donor Renal Transplantation; Acute Renal Allograft Rejection; Induction Therapy
19
No longer available
B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Last Updated: March 7, 2012
Condition(s): Type 1 Diabetes Mellitus
20
Completed
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids
Last Updated: January 28, 2011
Condition(s): Denovo Renal Transplantation

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Basiliximab+Simulect

Page 1 of Clinical Trials for Drug Basiliximab Simulect, 94 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About